Literature DB >> 7782783

Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1.

M S Ecob-Prince1, K Hassan, M T Denheen, C M Preston.   

Abstract

Explanation into culture of dorsal root ganglia (DRG) latently infected with herpes simplex virus type 1 (HSV-1) causes reactivation of the virus. Previous studies have suggested that either latency-associated transcripts (LATs) were removed as an early consequence of reactivation or, alternatively, there was a population of latently infected cells which did not contain LATs. We have now attempted to detect this population of neurons by inserting a reporter gene (Escherichia coli lacZ gene), under the control of promoters other than LAT, into the HSV-1 strain 17 mutant in 1814, which was used in the earlier studies. One of these promoters, the human cytomegalovirus enhancer, resulted in weak expression of beta-galactosidase in DRG neurons for at least 5 months. The pattern of staining was predominantly homogeneous in neurons at 3 or 5 days post-infection or at 3 days post-explanation, and was predominantly speckled in latently infected neurons (1 to 5 months post-infection). About 30% of the beta-galactosidase-positive neurons did not contain LATs by in situ hybridization. However, the detergents used to enable penetration of the substrate for beta-galactosidase had also reduced the levels of the LATs; in neurons which originally had only small numbers of LATs this may have reduced levels to below those detectable by the methods used. There was, therefore, no unequivocal evidence for a population of latently HSV-1-infected cells which did not express LATs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782783     DOI: 10.1099/0022-1317-76-6-1527

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 3.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

4.  Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.

Authors:  John W Balliet; Anna S Kushnir; Priscilla A Schaffer
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

Review 5.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

6.  Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

Authors:  R H Lachmann; S Efstathiou
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells.

Authors:  Y H Su; R L Meegalla; R Chowhan; C Cubitt; J E Oakes; R N Lausch; N W Fraser; T M Block
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.

Authors:  M J Nicholl; C M Preston
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency.

Authors:  J M Hill; B M Gebhardt; R Wen; A M Bouterie; H W Thompson; R J O'Callaghan; W P Halford; H E Kaufman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

10.  A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.

Authors:  Bernadette M Dutia; Stuart J Reid; Derek D Drummond; Yvonne Ligertwood; Ian Bennet; Willard Rietberg; Ondine Silvia; Michael A Jarvis; Anthony A Nash
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.